These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33047497)

  • 21. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Gebhardt E; Raballo A
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):337-350. PubMed ID: 31055617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.
    Edwards SJ; Barton S; Bacelar M; Karner C; Cain P; Wakefield V; Marceniuk G
    Health Technol Assess; 2021 Mar; 25(23):1-138. PubMed ID: 33783345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
    Tappenden P; Campbell F; Rawdin A; Wong R; Kalita N
    Health Technol Assess; 2012; 16(20):1-72. PubMed ID: 22490205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceived stress mediates the relationship between social adaptation and quality of life in individuals at ultra high risk of psychosis.
    Ortega L; Montalvo I; Monseny R; Vilella E; Labad J
    Early Interv Psychiatry; 2019 Dec; 13(6):1447-1454. PubMed ID: 30690915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of psychotic experiences in the early stages of mental health problems in young people.
    Heinze K; Lin A; Nelson B; Reniers RLEP; Upthegrove R; Clarke L; Roche A; Lowrie A; Wood SJ
    BMC Psychiatry; 2018 Jun; 18(1):214. PubMed ID: 29954377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation.
    Avenell A; Robertson C; Skea Z; Jacobsen E; Boyers D; Cooper D; Aceves-Martins M; Retat L; Fraser C; Aveyard P; Stewart F; MacLennan G; Webber L; Corbould E; Xu B; Jaccard A; Boyle B; Duncan E; Shimonovich M; Bruin M
    Health Technol Assess; 2018 Nov; 22(68):1-246. PubMed ID: 30511918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Rohrbach PJ; Dingemans AE; Evers C; Van Furth EF; Spinhoven P; Aardoom JJ; Lähde I; Clemens FC; Van den Akker-Van Marle ME
    J Med Internet Res; 2023 Jan; 25():e38204. PubMed ID: 36602854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood adversities in people at ultra-high risk (UHR) for psychosis: a systematic review and meta-analysis.
    Peh OH; Rapisarda A; Lee J
    Psychol Med; 2019 May; 49(7):1089-1101. PubMed ID: 30616701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis.
    Carney R; Cotter J; Bradshaw T; Firth J; Yung AR
    Schizophr Res; 2016 Feb; 170(2-3):290-300. PubMed ID: 26794596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.